戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 preterm infants (birth weight <1500 g and/or gestational age <32 weeks) was carried out.
2                      Exclusion criteria were gestational age <32 weeks, birth weight <1000 g, known i
3  1.10; 95% CI, 0.85 to 1.43), small size for gestational age (171 cases among 1768 exposed pregnancie
4 erm birth (ARR, 1.16) but not with small for gestational age (ARR, 1.19), stillbirth (ARR, 1.11), or
5 dence interval [CI], 1.36-1.75) or small for gestational age (ARR, 1.30; 95% CI, 1.07-1.57) but not o
6 erm birth (<37 gestational weeks), small for gestational age (birth weight <2 SDs below the mean for
7  discordant on sex-specific birth weight for gestational age (BW/GA) in order to minimize confounding
8 ristic four chambered appearance by 56 days gestational age (DGA).
9 ional study, 239 former preterm infants with gestational age (GA) </= 32 weeks and 264 former full-te
10 mass (FFM), and percentage body fat (PBF) by gestational age (GA), with the use of air-displacement p
11                                 To develop a gestational age (GA)-specific case definition for NEC.
12                         Being born large for gestational age (LGA) is a marker of increased growth ve
13 mall for gestational age (SGA) and large for gestational age (LGA), defined as birth weight <10(th) o
14 ivery (linear, p<0.0001) and being small for gestational age (linear, p=0.0027), with adjusted ORs of
15  improved, with lower incidence of large for gestational age (odds ratio 0.51, 95% CI 0.28 to 0.90; p
16  [95% CI, 1.18-1.52]) but not with small for gestational age (OR, 1.01 [95% CI, 0.81-1.25]), autism s
17 OR, 14.3; 95% CI, 2.77-73.5]), and small for gestational age (OR, 14.3; 95% CI, 1.62-126.1).
18 owed a significant negative association with gestational age (P < .0001) in the combined cohort, with
19 ntervals (CIs) in the incidence of small for gestational age (SGA) and large for gestational age (LGA
20 ; malformations; preterm delivery; small for gestational age (SGA) baby; need for the neonatal intens
21 dmission, congenital malformation, small for gestational age (SGA), birth injury, low Apgar score (</
22 nal status is a key determinant of small for gestational age (SGA), but some knowledge gaps remain, p
23  was compared with birth outcomes [small for gestational age (SGA), preterm birth (PTB)].In an observ
24 h, preterm birth (<37 weeks), small size for gestational age (SGA; <10th percentile of weight for ges
25 WAS) included 174 Finnish preterm infants of gestational age 24-30 weeks.
26 y significant PDA (mean [standard deviation] gestational age 25.7 [1.2] weeks and birth weight 813 [1
27 s of gestation (stratified according to sex, gestational age [<27 weeks or 27 to <29 weeks], and cent
28 (mean [standard deviation] BW = 864 [212] g; gestational age [GA] = 27 [2.2] weeks) who underwent an
29          To estimate the association between gestational age and 4 outcomes in school-aged children:
30                                        Lower gestational age and birth weight z-scores were associate
31          These factors vary by cell type and gestational age and can be affected by changes to the in
32 gnant women was recruited before 24 weeks of gestational age and followed until the end of pregnancy.
33 hers, after adjustment for chronological and gestational age and receipt of diphtheria and tetanus to
34       This investigation highlights that low gestational age and refraction of the eye are independen
35 s were analyzed, and their associations with gestational age and retinopathy of prematurity were exam
36  <10(th) or >90(th) centile respectively for gestational age and sex, were examined using linear and
37  the left and a positive correlation between gestational age and the level of cerebral hemoglobin con
38 s index (BMI) and rates of cerebral palsy by gestational age and to identify potential mediators of t
39 d by using logistic regression analysis with gestational age as a covariate.
40 I, 1.20-1.53) preterm birth, being small for gestational age at birth (aRR, 1.25; 95% CI, 1.13-1.30),
41 ity (CHOP ROP) model uses birth weight (BW), gestational age at birth (GA), and weight gain rate to p
42                                 Median (IQR) gestational age at birth was 29.9 (28.7-31.2) weeks.
43           Median (interquartile range [IQR]) gestational age at birth was 29.9 (28.7-31.2) weeks.
44 lected from patient charts including gender, gestational age at birth, birthweight, stage of ROP at p
45  violence, pre- and early postpartum stress, gestational age at birth, infant sex, and postnatal age
46 ng disease among infants less than 33 weeks' gestational age at birth.
47 be influenced by exposure to HIV and size or gestational age at birth.
48 ed sex, month of birth during the same year, gestational age at delivery, Apgar score at 5 minutes, m
49 glucocorticoid administration, preeclampsia, gestational age at delivery, days in intensive care unit
50 s, accounting for time under observation and gestational age at enrollment, were used to calculate ha
51 ne placebo in blocks of eight, stratified by gestational age at enrolment (17-25 weeks vs 26-34 weeks
52                                   The median gestational age at fetal MRI was 32.3 weeks of pregnancy
53     We stratified women by site and by their gestational age at randomisation (before week 26 and 0 d
54  preterm birth, why treatment was given, the gestational age at which magnesium sulphate treatment wa
55  the woman was at risk of preterm birth, the gestational age at which magnesium sulphate treatment wa
56  P<0.001), with increased rates of small for gestational age births (15% versus 8%; P=0.03).
57 udy of preterm infants younger than 28 weeks gestational age born between January 1, 2006, and Decemb
58 ble information on last menstrual period and gestational age confirmed by crown-rump length measured
59 birth weight compared to white infants were: gestational age for black infants, height and body mass
60              Randomization was stratified by gestational age groups.
61                                     Although gestational age has long been associated with poor educa
62 ated that induction of labour at 39 weeks of gestational age has no short-term adverse effect on the
63  birth rates and survival of babies with low gestational age improve.
64 ter of human pregnancy are lost in large-for-gestational age infants and may be regulated by BMAL1.
65 an placentas from pregnancies with large-for-gestational age infants and this overlapped with an incr
66                        The rate of small for gestational age infants was not modified by immunisation
67 nant women with normally grown and large-for-gestational age infants.
68  the reliance on observational data in which gestational age is recorded in weeks rather than days.
69 ngitudinal study of 587 preterm infants with gestational age less than 34 weeks and birth weights bet
70                               METHODS AND At gestational age mean 32 weeks (early) and mean 37 weeks
71  2011, 832 women entered the trial at a mean gestational age of 10.7 weeks (SD 2.7); median urinary i
72 e, intrauterine gestation corresponding to a gestational age of 11 weeks and 5 days.
73 rain abnormality detected by ultrasound at a gestational age of 18 weeks or more, had no contraindica
74    462 (3.2%) of 14 678 babies born before a gestational age of 32 weeks developed severe necrotising
75 ute risk difference for babies born before a gestational age of 32 weeks who received their own mothe
76                   Among babies born before a gestational age of 32 weeks, the adjusted network incide
77      In the subgroup of babies born before a gestational age of 32 weeks, we did a propensity score a
78  networks, of whom 14 678 were born before a gestational age of 32 weeks.
79 A1 (Gravida2, para0, abortion1) woman with a gestational age of around 12 weeks was referred for a ro
80 live, intrauterine foetus corresponding to a gestational age of around 22 weeks and 4 days.
81 SE REPORT: A 25-year-old G1P0A0 woman with a gestational age of around 22 weeks was referred for an a
82 pared all live births and stillbirths with a gestational age of at least 24 weeks in 8 geographically
83 m January 1, 2000 to December 31, 2010, at a gestational age of at least 24 weeks.
84 o underwent NBS and had confirmed CF, with a gestational age of at least 35 weeks, birth weight of at
85                                       Median gestational age of CCC infants was 26 3/7 (range, 23 0/7
86                      Exclusion criteria were gestational age of less than 32 weeks, birth weight of l
87 e found no association between endoscopy and gestational age or birth weight.
88 n was found between the ffERG recordings and gestational age or retinopathy of prematurity in the pre
89 io [OR], 1.47 [95% CI, 1.40-1.55]; small for gestational age OR, 1.15 [95% CI, 1.06-1.25]; autism spe
90 ery and 1.12 (1.04-1.21) for being small for gestational age per unit increase in Ln-vanadium concent
91 e of preterm birth (<37 weeks) and small for gestational age status (SGA) among infants exposed prena
92 pleted; mean birth weight was 709 g and mean gestational age was 24.9 weeks.
93 eligible survivors, 1503 were assessed (mean gestational age was 26.3 weeks; 68% were white, 9% were
94 VLBW cohort, 55% were male and the mean (SD) gestational age was 26.87 (2.40) weeks.
95                                   The median gestational age was 27 weeks (range, 25-29 weeks).
96 infants (54.3%) were boys, and the mean (SD) gestational age was 28.5 (2.2) weeks and mean (SD) birth
97 % of the infants were male and the mean (SD) gestational age was 38.38 (1.87) weeks.
98                                   Decreasing gestational age was associated with lower height (-1.1 m
99                                              Gestational age was inversely associated with the risk o
100 among preterm neonates younger than 28 weeks gestational age was not associated with the composite ou
101 ed into stillbirths and miscarriages because gestational age was not reliably reported.
102 tudy, including preterm children (<27 weeks' gestational age) and children born at term, at 6.5 years
103 nal age (SGA; <10th percentile of weight for gestational age) or neonatal death (<28 days from delive
104 n intermediates (preterm birth and small for gestational age) with sensitivity analyses.
105  age (birth weight <2 SDs below the mean for gestational age), and first inpatient or outpatient clin
106 ks), very SGA (<3rd percentile of weight for gestational age), stillbirth, and neonatal death.
107 infected prior to the first antenatal visit (gestational age, <120 days) and not later in pregnancy.
108 ndomized (mean age, 29 [SD, 6.3] years; mean gestational age, 22 [SD, 1.3] weeks), 100% completed the
109 nd detected RW-ROP in 123 infants (mean [SD] gestational age, 24.6 [1.5] weeks) at the same time (sam
110      Image grading in 123 infants (mean [SD] gestational age, 24.8 [1.4] weeks) detected RW-ROP earli
111 n, stage 3 or more in 123 infants (mean [SD] gestational age, 24.8 [1.4] weeks) ROP was noted earlier
112                Among 1580629 offspring (mean gestational age, 279 days; 48.6% female; 1.4% [n = 22544
113 oys [52.0%] and 259 girls [48.0%]; mean [SD] gestational age, 39.2 [1.1] weeks), 270 each were random
114           Of 1423929 children included (mean gestational age, 39.8 weeks [SD, 1.8]; 51.4% male), 3029
115 exposed vs 2.19% of unexposed were small for gestational age, 5.28% of exposed vs 2.14% of unexposed
116                                              Gestational age, age at illness onset, exposure to envir
117 ingleton, birth weight appropriate for their gestational age, and medically stable).
118   Maternal young age, term infant, small for gestational age, and the presence of ophthalmologic abno
119  final height was associated with decreasing gestational age, and this association was particularly m
120 erm birth but no increased risk of small for gestational age, autism spectrum disorder, or attention-
121                         Clinical parameters (gestational age, birth body weight, mode of delivery and
122              Infants with lesions had higher gestational age, birth weight, and less chronic lung dis
123 ms adjusted for infant characteristics (sex, gestational age, birthweight, parity and breast feeding)
124 increased risk of preterm birth or small for gestational age, but not of congenital malformation or s
125  cases with known birthweight were small for gestational age, compared with eight (5%) of 173 control
126 illbirth, major birth defect, small size for gestational age, low birth weight, and preterm birth.
127 ations were controlled for date of delivery, gestational age, maternal body mass index, maternal age,
128 tcomes (preterm birth, stillbirth, small for gestational age, or congenital malformations) in women w
129 nts, adjusting in linear regression for sex, gestational age, race/ethnicity, maternal BMI, study sit
130 tres), astigmatism, birth weight percentile, gestational age, retinopathy of prematurity occurrence,
131  The risk of very low birthweight, small for gestational age, severe small for gestational age, still
132 ve and -negative preterm infants matched for gestational age, sex, race, prenatal steroid exposure, a
133  small for gestational age, severe small for gestational age, stillbirth, and congenital anomalies di
134 , enrollment in public pre-Kindergarten, and gestational age, to determine the association of CHD wit
135 ircumference 3 SD below the mean for sex and gestational age, was found in 72 (82%) infants.
136 and gifted status were positively related to gestational age, whereas low performance was inversely r
137 ophthalmologist), CHOP-ROP (birth weight and gestational age, with weekly weight gain initiating exam
138  time series were acquired at 29 to 34 weeks gestational age.
139 he other countries, even after adjusting for gestational age.
140 very mode, offspring gender, birthweight and gestational age.
141 the infants were more likely to be small for gestational age.
142 tifying FGR among fetuses that are small for gestational age.
143 livery, low birthweight, and being small for gestational age.
144 eas low performance was inversely related to gestational age.
145 using Tdap date, infant's date of birth, and gestational age.
146  for parental ADHD, infant birth weight, and gestational age.
147 usion significantly increased with advancing gestational age; however, no such correlation was found
148 entas from term infants born appropriate-for-gestational-age (AGA) or small-for-gestational-age (SGA)
149 ponectin throughout pregnancy with large-for-gestational-age (LGA) births and BW z-score.
150  [OR] 5.41; 95% CI:0.99,29.52) and small-for-gestational-age (OR: 3.65; 95% CI: 1.01,13.38).
151                                    Small-for-gestational-age (SGA) and preterm births were examined a
152        Recent studies finding that small-for-gestational-age (SGA) birth is associated with increased
153 riate-for-gestational-age (AGA) or small-for-gestational-age (SGA) to identify new genes related to f
154  outcomes (low BW [LBW], <2500 g), small-for-gestational-age [SGA], and BW z scores [BWZ]) in HIV-exp
155 9; p value for interaction 0.049), small-for-gestational-age births (0.92, 0.87-0.97; p=0.03), and 6-
156                  The prevalence of small-for-gestational-age births and low Apgar score (<7) did not
157 f preterm birth, low birth weight, small-for-gestational-age births, cesarean delivery, and low Apgar
158 acrosomic, small- (SGA) and large- (LGA) for-gestational-age infants.
159      Women delivered 36 LGA and 11 small-for-gestational-age newborns.
160 logical distress, prematurity, and small-for-gestational-age, also were comparable.
161 th similar effects across a range of preterm gestational ages and different treatment regimens.
162 2011 and 2012 on 4594 singleton infants with gestational ages between 24 and 31 weeks, without severe
163 ure had retarded intrauterine growth between gestational ages of 212 and 253 days (difference between
164    A total of 1527113 singleton infants with gestational ages of 23 to 41 weeks born between 1992 and
165 tal origin was present in the chorion at all gestational ages, associated with stromal cells or near
166 rth to infants who were born small for their gestational ages.
167 n described to impart adverse effects during gestational and lactational exposure.
168          Overall, our findings reaffirm that gestational and neonatal challenges can result in long-t
169 tes were frequency matched according to sex, gestational and postnatal age, and preimaging serum Cr l
170 between maternal diabetes (pregestational or gestational) and each CHD phenotype, adjusting for poten
171                                              Gestational bisphenol-A in male mice primed macrophages
172                                We found that gestational, but not adult, exposure to bisphenol-A incr
173                 Previously, we reported that gestational carbofuran exposure has detrimental effects
174 ng and addresses the gaps in knowledge about gestational changes in hematologic and iron variables an
175 ed air (FA) throughout pregnancy [6 h/d from gestational day (GD) 0.5 through GD16.5].
176 (G)-nitroarginine methyl ester (L-NAME) from gestational day (GD) 11 to GD18 to induce hypertension.
177                                           At gestational day (GD) 12.5, GDM produced a hyperglycemic,
178                                           On gestational day (GD) 15.5-17.5, dams were injected with
179  I:C), which simulates a viral infection, on gestational day 12.5 according to an established materna
180 served that chronic carbofuran exposure from gestational day 7 to postnatal day 21 altered expression
181  25mug/kg/day BPA via osmotic minipumps from gestational day 8 through postnatal day (PND)16.
182 nant dams were injected intraperitoneally at gestational day 9 with polyinosinic:polycytidylic acid.
183                                           On gestational days 85 and 135, they underwent placental ma
184                          We report that late gestational deletion of the angiopoietin receptor endoth
185                        Treatment options for gestational diabetes (GDM) are limited.
186 263 offspring aged 1-5 years of mothers with gestational diabetes (GDM) in a cross-sectional study.
187  al.:1115-1124) clearly documented that both gestational diabetes and hypertension lead to diabetes a
188  the past, it was thought that most cases of gestational diabetes and hypertension would resolve afte
189     Early identification of women at risk of gestational diabetes and hypertension, better treatment
190 s contributed to an increase in the rates of gestational diabetes and hypertension.
191 improve our understanding of the etiology of gestational diabetes and hypertension.
192                  The conjoint association of gestational diabetes mellitus (GDM) and gestational hype
193  of MP-1 (TIMP-1) in biofluids of women with gestational diabetes mellitus (GDM) and systemically hea
194                                              Gestational diabetes mellitus (GDM) is conventionally co
195 rding the role of iron in the development of gestational diabetes mellitus (GDM), a common pregnancy
196          We examined the association between gestational diabetes mellitus (GDM), a state of transien
197 s) with impaired glucose tolerance (IGT) and gestational diabetes mellitus (GDM), and we used linear
198 metabolism biomarkers among women with prior gestational diabetes mellitus (GDM).
199 ia has been widely observed in patients with gestational diabetes mellitus (GDM).
200  the association between age at menarche and gestational diabetes mellitus (GDM).
201 nal cohort that oversampled pregnancies with gestational diabetes mellitus (GDM).Six hundred eight wo
202  among high-risk children born to women with gestational diabetes mellitus (GDM).The analysis include
203 vidual healthy behaviors and reduced risk of gestational diabetes mellitus (GDM); however, the associ
204 ht women with an index pregnancy affected by gestational diabetes mellitus and 626 controls enrolled
205 culates at high concentrations in type 2 and gestational diabetes patients.
206 ted for many CHD phenotypes among women with gestational diabetes.
207 vide a biomarker of a coexisting systemic or gestational disorder and a potential reason for a matern
208                                              Gestational disruptions in metabolic rhythmicity of the
209 , ADCY5, and RAP2C loci were associated with gestational duration and variants at the EBF1, EEFSEC, a
210 from 43,568 women of European ancestry using gestational duration as a continuous trait and term or p
211 tion between variants in ADCY5 and RAP2C and gestational duration had suggestive significance in the
212    We used large data sets that included the gestational duration to determine possible genetic assoc
213 and WNT4) were significantly associated with gestational duration.
214  growth, particularly in response to adverse gestational environments.
215 atistically significant relationship between gestational exposure and mortality.
216 iland, July 2004.The effect of the length of gestational exposure of the new ration on fetal growth w
217        We estimated the associations between gestational exposure to select phthalates and phenols an
218                             We reported that gestational exposure to sidestream cigarette smoke (SS),
219 nsion in the general population, but data on gestational hypertension (GH) are limited.
220 n of gestational diabetes mellitus (GDM) and gestational hypertension (GH) with cardiometabolic disea
221 .06-1.27), but they were not associated with gestational hypertension (OR, 1.07; 95% CI, 0.92-1.25).
222 ny hypertensive disorder in pregnancy (HDP) (gestational hypertension [GH], preeclampsia, or eclampsi
223  HDP for ischemic stroke, late menopause and gestational hypertension for hemorrhagic stroke, and oop
224 ies in donors may incur attributable risk of gestational hypertension or preeclampsia (11% versus 5%
225 ious pregnancy, but not term preeclampsia or gestational hypertension, was associated with offspring
226 th term preeclampsia and not associated with gestational hypertension.
227 preterm preeclampsia, term preeclampsia, and gestational hypertension.
228 m preeclampsia: OR, 0.98; 95% CI, 0.88-1.10; gestational hypertension: OR, 1.13; 95% CI, 0.92-1.38).
229 g prenatal development, following periods of gestational hypoxia and placental oxidative stress.
230                                              Gestational hypoxia caused low birth-weight and changes
231                      Here we investigated if gestational hypoxia promotes damaging secretions from th
232 ocioeconomic disadvantage is associated with gestational immune activity and whether such activity is
233 er, and by toxicity influences birth weight, gestational length, or birth abnormalities.
234       Models adjusted for sex, birth weight, gestational length, season of birth, temperature, relati
235                         After adjustment for gestational length, the decline in birth weight was atte
236 GE2 or 15-PGDH inhibitor alone did not alter gestational length, treatment with 15-PGDH inhibitor + P
237 n with ASD+ID had significantly elevated mid-gestational levels of numerous cytokines and chemokines,
238 received abortions just under the facility's gestational limit (near-limit group) and compared them w
239 n because they were just beyond the facility gestational limit (turnaway group, which includes the tu
240              Our findings support a role for gestational maternal infection and innate immune respons
241 he choriodecidual surface of explanted human gestational membranes.
242 ypic change in BAT, which contributes to the gestational metabolic environment, and thus overall feta
243  of brown adipose tissue (BAT) in regulating gestational metabolism is unknown.
244 is characterized by recurrent thrombosis and gestational morbidity in patients with antiphospholipid
245 the effects of CAPs exposure during discrete gestational periods (1: GD0.5-5.5; 2: GD6.5-14.5; 3: GD1
246 oximately 0.4d when exposure occurred during gestational periods 2 and 4, and by approximately 0.5d i
247                We investigated how metabolic gestational processes are coordinated, whether there is
248    Herein, we report a case of bilateral non-gestational pure primary ovarian choriocarcinoma that wa
249  examination, the diagnosis of bilateral non-gestational pure primary ovarian choriocarcinoma was mad
250  were found to be specific for bilateral non-gestational pure primary ovarian choriocarcinoma.
251 (Gcn5(hat/hat) ) mutants can be rescued with gestational RA supplementation, supporting a direct link
252 ristic features are empty uterus and cervix, gestational sac in the anterior part of lower uterine se
253 ious LSCS delivery in a female with a viable gestational sac in the lower uterine segment and elevate
254 regnancy, where there is implantation of the gestational sac onto the anterior wall of the uterus at
255 to be a site of improper implantation of the gestational sac.
256   In the current study, we characterized mid-gestational serum profiles of 22 cytokines and chemokine
257        Thus the intergenerational effects of gestational SS involve epigenetic regulation of HIF-1alp
258                Our data establish a model of gestational stage dependence of ZIKV pathogenesis and IF
259          Although these defects decline with gestational stage, they remain sufficiently severe at bi
260 ore susceptible to ZIKV infection at earlier gestational stages.
261 mug CAPs/m(3) throughout pregnancy decreased gestational term by 0.5 d ( approximately 1.1 wk decreas
262 anced recruitment of L. monocytogenes to the gestational uterus but rather is due to compromised loca
263 on complex diseases that may be prevented by gestational vitamin D repletion.
264 starting supplement use on or after the 12th gestational week (6.9%, 7.2%, and 6.4%, respectively).
265 286 nonpsychiatric control individuals, from gestational week 14 to 85 years old, and individuals dia
266 d by using a food-frequency questionnaire in gestational week 25.
267  in maternal peripheral blood at enrollment, gestational week 30-32, and delivery, and in placental b
268 halate exposure and clinical pregnancy loss (gestational weeks >6).
269                       Stratified analysis by gestational weeks (10 weeks) of miscarriage indicated po
270 te this, we exposed human fetal testes (7-17 gestational weeks (GW)) to ibuprofen using ex vivo cultu
271 g the 3 months before conception and, during gestational weeks 1-20, 17% for nitrogen oxides, 10% for
272  The only association of foetal loss (during gestational weeks 11 to 27) was observed with MEHHP.
273    Available evidence has suggested that, in gestational weeks 32-39, the median or geometric mean SF
274 PLC-MS/MS) in urine samples collected during gestational weeks 38.8+/-1.1 from 398 pregnant women in
275                 Morning urine samples during gestational weeks 5 to 14 (mean 10.42) were collected to
276 HP and SigmaHMWP with embryonic loss (during gestational weeks 6 to 10).
277 ate metabolites and clinical pregnancy loss (gestational weeks 6 to 27; n = 109).
278 all singleton births at 22 or more completed gestational weeks in Sweden from 1997 through 2011; of t
279 3 live single births at 22 or more completed gestational weeks in Sweden from January 1, 1997, to Dec
280 ort study included 12 018 infants born at 28 gestational weeks or younger discharged between January
281                           Preterm birth (<37 gestational weeks), small for gestational age (birth wei
282 fined as birth occurring before 37 completed gestational weeks).
283                         To determine whether gestational weight gain (GWG) during pregnancy and mater
284 Women with asthma exacerbation(s) had larger gestational weight gain (GWG) in the first trimester of
285                                              Gestational weight gain (GWG) is an important modifiable
286 ernal pre-pregnancy body mass index (BMI) or gestational weight gain (GWG) is associated with unfavor
287 y mass index (BMI; weight (kg)/height (m)2), gestational weight gain (GWG), birth size, and childhood
288                                              Gestational weight gain during pregnancy, maternal body
289  index for all Asian and Samoan mothers, and gestational weight gain for Japanese mothers.
290 ncy BMI has a stronger influence than either gestational weight gain or postpartum weight retention.
291        Maternal obesity and higher early-mid gestational weight gain were associated with NAFLD in fe
292 tional recommendations for prepregnancy BMI, gestational weight gain, and postpartum weight retention
293 regnancy body mass index [BMI (in kg/m(2))], gestational weight gain, and postpartum weight retention
294 hat differences in maternal anthropometrics, gestational weight gain, and preterm birth rate, but not
295 t (P < 0.05) after additional adjustment for gestational weight gain, birth weight, and children's in
296  = 0.001), but not parental age nor maternal gestational weight gain, were associated with NAFLD in m
297 eonate offered by greater preconceptional or gestational weight may be most pronounced in more undern
298 ancy.We investigated how preconceptional and gestational weight trajectories (summarized by individua
299 say (FEGA) with tissue obtained at 10 and 12 gestational wk (GW 10-12), to screen 27 chemicals indivi
300 case-control study cohort, containing 33,935 gestational women in West China Second Hospital.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top